Leukemia News and Research

RSS
Leukemia (Leukaemia) is a cancer of the blood cells. It is the most common type of blood cancer and affects 10 times as many adults as children. Most people diagnosed with leukemia are over 50 years old. No one knows why some people develop leukemia and others do not. However, scientists have identified some risk factors for the disease. Most people who have known risk factors do not get leukemia, while many who do get the disease have none of these risk factors. During the early stages of leukemia, there may be no symptoms. Many of the symptoms of leukemia don't become apparent until a large number of normal blood cells are crowded out by leukemia cells.
Genetic marker, predictor of early relapse in common childhood cancer discovered

Genetic marker, predictor of early relapse in common childhood cancer discovered

Research advances offer hope for patient-tailored AML treatment

Research advances offer hope for patient-tailored AML treatment

New technology for profiling genetic makeup of myeloma tumor cells developed

New technology for profiling genetic makeup of myeloma tumor cells developed

CZI announces funding for open-source software efforts to improve image analysis in biomedicine

CZI announces funding for open-source software efforts to improve image analysis in biomedicine

Physician-scientists present updated efficacy data on CAR T-cell gene immunotherapy

Physician-scientists present updated efficacy data on CAR T-cell gene immunotherapy

Study: 39% of B cell lymphoma patients treated with CAR T therapy remain in remission

Study: 39% of B cell lymphoma patients treated with CAR T therapy remain in remission

New strategies may improve performance of CAR-T cell therapy in treating cancer

New strategies may improve performance of CAR-T cell therapy in treating cancer

Research highlights ability of Bio-Rad's ddPCR in quantifying minimal residual disease

Research highlights ability of Bio-Rad's ddPCR in quantifying minimal residual disease

SSB enters into collaboration with Immunochina to develop new immunotherapy equipment

SSB enters into collaboration with Immunochina to develop new immunotherapy equipment

Study: 51% of patients alive two years after receiving CAR-T therapy for diffuse large B-cell lymphoma

Study: 51% of patients alive two years after receiving CAR-T therapy for diffuse large B-cell lymphoma

Cleveland Clinic expert develops personalized prediction model for Myelodysplastic Syndromes

Cleveland Clinic expert develops personalized prediction model for Myelodysplastic Syndromes

CAR T therapy can lead to long-lasting remissions in patients with r/r diffuse large B-cell lymphoma

CAR T therapy can lead to long-lasting remissions in patients with r/r diffuse large B-cell lymphoma

FDA approves new combination therapy for acute myeloid leukemia

FDA approves new combination therapy for acute myeloid leukemia

Triple combination cancer immunotherapy improves survival in mouse model of melanoma

Triple combination cancer immunotherapy improves survival in mouse model of melanoma

Researchers identify inconspicuous protein as key to aggressive blood cancer

Researchers identify inconspicuous protein as key to aggressive blood cancer

Report recommends creation of health monitoring, research program on Gulf War and post-9/11 veterans

Report recommends creation of health monitoring, research program on Gulf War and post-9/11 veterans

DNA mutations in healthy and leukemic blood stem cells do not differ, shows research

DNA mutations in healthy and leukemic blood stem cells do not differ, shows research

New method could improve outcome of leukemia patients receiving stem-cell transplants

New method could improve outcome of leukemia patients receiving stem-cell transplants

Using molecular targeting approach to kill melanoma cells

Using molecular targeting approach to kill melanoma cells

Researchers identify powerful inhibitor of epigenetic factors that promote acute myeloid leukemia

Researchers identify powerful inhibitor of epigenetic factors that promote acute myeloid leukemia